Skip to content
10-K

Annual Report

Concert Pharmaceuticals, Inc.

0001367920-22-000018

← back to feed
Filed
Mar 3, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Feb 28, 2022 34.95M sh
Shares Diluted FY 2021 · Dec 31, 2021 34.41M sh
Shares Diluted FY 2021 · Dec 31, 2020 31.2M sh
Capex FY 2021 · Dec 31, 2021 $255K
Capex FY 2021 · Dec 31, 2020 $210K
Operating Cash Flow FY 2021 · Dec 31, 2021 −$55.15M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$69.04M
Cash And Equivalents FY 2021 · Dec 31, 2021 $141.64M
Cash And Equivalents FY 2021 · Dec 31, 2020 $77.2M
Stockholders Equity FY 2021 · Dec 31, 2021 $112.23M
Stockholders Equity FY 2021 · Dec 31, 2020 $131.16M
Stockholders Equity FY 2021 · Dec 31, 2019 $101.46M
Current Liabilities FY 2021 · Dec 31, 2021 $16.12M
Current Liabilities FY 2021 · Dec 31, 2020 $10.18M
Total Liabilities FY 2021 · Dec 31, 2021 $53.09M
Total Liabilities FY 2021 · Dec 31, 2020 $28.1M
Current Assets FY 2021 · Dec 31, 2021 $150.33M
Current Assets FY 2021 · Dec 31, 2020 $142.72M
Total Assets FY 2021 · Dec 31, 2021 $165.32M
Total Assets FY 2021 · Dec 31, 2020 $159.26M
Eps Diluted FY 2021 · Dec 31, 2021 −$2.33
Eps Diluted FY 2021 · Dec 31, 2020 −$2.40
Eps Basic FY 2021 · Dec 31, 2021 −$2.33
Eps Basic FY 2021 · Dec 31, 2020 −$2.40
Sga Expense FY 2021 · Dec 31, 2021 $22.53M
Sga Expense FY 2021 · Dec 31, 2020 $18.93M
Rd Expense FY 2021 · Dec 31, 2021 $87.56M
Rd Expense FY 2021 · Dec 31, 2020 $61.62M
Net Income FY 2021 · Dec 31, 2021 −$80.05M
Net Income FY 2021 · Dec 31, 2020 −$74.77M
Operating Income FY 2021 · Dec 31, 2021 −$77.51M
Operating Income FY 2021 · Dec 31, 2020 −$72.65M
Revenue FY 2021 · Dec 31, 2021 $32.58M
Revenue FY 2021 · Dec 31, 2020 $7.9M
Revenue restated FY 2021 · Mar 31, 2018 $10.5M
Revenue FY 2021 · Mar 19, 2018 $10.5M